Heart Failure, Diastolic: Clinical Trials

13 trials for Heart Failure, Diastolic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 terminated, 2 unknown, 1 recruiting. 13 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 313Completed 8, Terminated 2, Unknown 2, Recruiting 1
Phase 24Completed 2, Terminated 2

Follow Heart Failure, Diastolic: new trials by email Literature Review of Heart Failure, Diastolic trials Research Report on Heart Failure, Diastolic

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Selenium Intervention Registry Randomized Trial in Heart Failure
Selenium Supplement, Placebo - Heart Failure, Heart Failure and Reduced Ejection Fraction
Phase 3RecruitingSkane University Hospital43262026-04-012026-04-22
A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction
Low calorie meal replacement plan, Cardiovascular magnetic resonance (CMR) imaging and magnetic resonance spectroscopy, Transthoracic echocardiography - Heart Failure With Preserved Ejection Fraction, Heart Failure, Diastolic
Phase 2 / Phase 3CompletedUniversity of Leicester662023-12-052026-07-22
Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years)
Screening and treatment of comorbidities, Placebo Comparator - Heart Failure, Diastolic
Phase 3UnknownGöteborg University4102014-09-012018-09-07
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
LCZ696, Valsartan - Heart Failure With Preserved Ejection Fraction
Phase 3CompletedNovartis Pharmaceuticals48222014-07-182020-09-29
Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer
Eplerenone, Placebo - Breast Cancer
Phase 2 / Phase 3TerminatedUniversity of British Columbia442014-05-012017-01-05
A Randomized Trial of Udenafil Therapy in Patients With Heart Failure With Preserved Ejection Fraction [ULTIMATE-HFpEF]
Placebo, Udenafil (Zydena) - Diastolic Heart Failure
Phase 3UnknownSeoul National University Hospital522012-10-012013-01-31
Denervation of the renAl sympathetIc nerveS in hearT Failure With nOrmal Lv Ejection Fraction
renal denervation - Diastolic Heart Failure, Hypertension
Phase 2 / Phase 3TerminatedUMC Utrecht602012-04-012021-05-03
Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH
Sildenafil, Placebo - Heart Failure, Diastolic, Pulmonary Hypertension
Phase 3CompletedUniversity Medical Center Groningen522011-10-012016-03-21
Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension
bosentan, placebo - Heart Failure, Diastolic, Hypertension, Pulmonary
Phase 3CompletedUniversity Teaching Hospital Hall in Tirol202009-01-012014-06-30
Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study)
Placebo, Sildenafil - Heart Failure
Phase 3CompletedDuke University2162008-09-012014-07-23
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Spironolactone, Placebo - Cardiovascular Diseases, Heart Diseases
Phase 3CompletedCarelon Research34452006-08-012015-03-02
Phosphodiesterase-5 (PDE5) Inhibition and Pulmonary Hypertension in Diastolic Heart Failure
Sildenafil, Placebo - Pulmonary Hypertension, Diastolic Heart Failure
Phase 2 / Phase 3CompletedUniversity of Milan442006-01-012012-06-15
PIE II: Pharmacological Intervention in the Elderly II
Spironolactone, Placebo - Diastolic Heart Failure, Heart Failure, Congestive
Phase 3CompletedWake Forest University802005-04-012019-02-27

Narrower conditions

Heart Failure (5)  ·  Hypertension, Pulmonary (3)  ·  Breast Neoplasms (1)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Heart Diseases (1)  ·  Heart Failure, Systolic (1)  ·  Hypertension (1)  ·  Obesity (1)

Broader conditions

Cardiovascular Diseases (12)  ·  Heart Diseases (12)  ·  Heart Failure (8)  ·  Vascular Diseases (4)  ·  Hypertension (3)  ·  Lung Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Body Weight (1)  ·  Breast Diseases (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

Sildenafil Citrate (3)  ·  Spironolactone (2)  ·  Bosentan (1)  ·  Diagnostic Imaging (1)  ·  Diet (1)  ·  Echocardiography (1)  ·  Electrocardiography (1)  ·  Eplerenone (1)  ·  Hematologic Tests (1)  ·  Mass Screening (1)  ·  Mineralocorticoid Receptor Antagonists (1)  ·  Positron-Emission Tomography (1)  ·  Sugars (1)  ·  Valsartan (1)  ·  Walk Test (1)

Sponsors

Carelon Research (1)  ·  Duke University (1)  ·  Göteborg University (1)  ·  Novartis Pharmaceuticals (1)  ·  Seoul National University Hospital (1)  ·  Skane University Hospital (1)  ·  UMC Utrecht (1)  ·  University Medical Center Groningen (1)  ·  University Teaching Hospital Hall in Tirol (1)  ·  University of British Columbia (1)  ·  University of Leicester (1)  ·  University of Milan (1)  ·  Wake Forest University (1)

Countries

Canada (4)  ·  United States (4)  ·  Netherlands (3)  ·  Sweden (3)  ·  Argentina (2)  ·  Austria (2)  ·  Brazil (2)  ·  Norway (2)  ·  Russia (2)  ·  South Korea (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  China (1)

Top investigators

Dalane W. Kitzman, MD (1)  ·  E S Hoendermis, MD PhD (1)  ·  Eugene Braunwald, MD (1)  ·  Gerry P McCann, MD (1)  ·  Goo-Yeong Cho, MD, PhD (1)  ·  Hyung-Kwan Kim, MD, PhD (1)  ·  In-Chang Hwang, MD (1)  ·  Kerry L. Lee, PhD (1)  ·  Kyung-Hee Kim, MD (1)  ·  Margot Davis, MD (1)  ·  Michael X Fu, Professor (1)  ·  Michiel Voskuil, MD, PhD (1)  ·  Sean A Virani, MD, MSc, MPH (1)  ·  Seung-Pyo Lee, MD (1)

Results publications

PMID 35603667, PMID 36632831, PMID 37366061, PMID 42669134, PMID 19850207, PMID 21709061, PMID 22991405, PMID 23258572, PMID 23478662, PMID 23883653, PMID 24162898, PMID 24249049, PMID 24716680, PMID 24833648, PMID 25104521, PMID 25122186, PMID 25406305, PMID 25415957, PMID 25648577, PMID 25782985, PMID 26130119, PMID 26188003, PMID 26374849, PMID 26475142, PMID 26962133, PMID 27039126, PMID 27056882, PMID 27072860, PMID 27873388, PMID 28194841, PMID 28214792, PMID 28322009, PMID 28359411, PMID 28637881, PMID 28662936, PMID 29094152, PMID 29148144, PMID 29228101, PMID 29501806, PMID 29664406, PMID 29890892, PMID 29980595, PMID 30007557, PMID 30140899, PMID 30571191, PMID 30571192, PMID 30819379, PMID 30871349, PMID 31214914, PMID 31220936

NIH funding

R01AG018915 (1), U01HL084904 (1)